Transplant Genomics - Ownership and Business Overview

Life ScienceCompany

Transplant Genomics Ownership

Who owns Transplant Genomics?

Transplant Genomics is owned by Eurofins Scientific SE. It was acquired on June 25, 2019.

Transplant Genomics Business Overview

Where is Transplant Genomics headquartered?

Transplant Genomics is headquartered in Brookline, Massachusetts.

What sector is Transplant Genomics in?

Transplant Genomics is a life science company.

When was Transplant Genomics founded?

Transplant Genomics was founded in 2013.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Transplant Genomics, Inc.

1501 Beacon Street, Suite 1903,
Brookline, Massachusetts 02446
United States,
(617) 733-0757
www.transplantgenomics.com

Transplant Genomics, Inc. is a molecular diagnostics company committed to improving organ transplant outcomes, with an initial focus on kidney transplant recipients. Transplant Genomics was founded in 2013 and is based in Brookline, Massachusetts.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.